Cell and Gene Logistics
-
3 Focus Areas To Transition From Clinical To Commercial Readiness
11/12/2024
Transitioning from clinical-stage operations to commercial readiness is a multifaceted process. Establish compliant and robust distribution systems by focusing on these three areas.
-
IntegriCell™ Cryopreservation Services From Cryoport Systems
11/7/2024
IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.
-
MACS® Freezing Solution
11/6/2024
The MACS Freezing Solution is a ready-to use serum-free and animal component-free media formulation developed for the cryopreservation of primary cells and solid tissues. The MACS Freezing Solution ensures high preservation of viability and recovery of cells and tissues after thawing.
-
Strengthening The Pharmaceutical Supply Chain For Single-Use Assemblies
11/6/2024
Dual sourcing strengthens the pharmaceutical supply chain for single-use assemblies. Learn how this strategy and multi-sourcing can enhance resilience and adaptability in the face of disruptions.
-
MACS® Cell Storage Solution
11/5/2024
Sometimes, primary cells cannot be used immediately for analysis, or they need to be shipped to different locations to be analyzed. If the cells are to be used within a few days, it is essential to store them in a supporting medium to ensure that cell viability and composition of the cell suspensions are preserved, as well as cell functionality is maintained.
-
Expert Insights In Navigating CGT's Complex Supply Chain
10/30/2024
Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.
-
A Comprehensive Guide For Supplier Quality Agreements
10/29/2024
This overview of SQAs includes a handy matrix template, which is useful for determining who is responsible for managing specific responsibilities.
-
Audience Q&A | From Bottleneck To Breakthrough: Reimagining The mRNA Therapeutics Supply Chain
10/28/2024
During every Cell & Gene Live, our expert panelists provide actionable responses to real-time questions from the audience. Here, panelists share information on categorizing raw materials, linear DNA, the future of the mRNA supply chain, and more.
-
Tips For Scaling mRNA Therapeutics
10/28/2024
In this segment, Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share their insight on what’s needed to achieve success in scaling mRNA therapeutics.
-
Is Cold Chain Really A Challenge Facing mRNA Therapeutics?
10/28/2024
mRNA product storage can be challenging due to extremely low temperature requirements. Here, Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share their take on existing cold chain challenges.